Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Retraction: JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Journal: Oncotarget
Published: April 24, 2026
Retraction: JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
Journal: Oncotarget
Published: April 24, 2026
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.
Journal: Oncotarget
Published: August 06, 2017
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.
Journal: Journal of hematology & oncology
Published: July 05, 2016
JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Journal: Oncotarget
Published: April 15, 2016
Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.
Journal: American journal of translational research
Published: January 18, 2016
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells.
Journal: Journal of hematology & oncology
Published: December 10, 2014
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
Journal: Oncotarget
Published: November 13, 2014
Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 12, 2014
Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma.
Journal: Gynecologic oncology
Published: October 12, 2012
Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et al.
Journal: American journal of obstetrics and gynecology
Published: March 03, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026